Patents by Inventor Frank Lucia

Frank Lucia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067973
    Abstract: The present invention refers to oligonucleotides comprising 10 to 25 nucleotides, wherein at least one of the nucleotides is modified, and the oligonucleotide hybridizes with mRNA of angiotensin-converting enzyme 2 (ACE2) of SEQ ID NO.1 and/or with pre-mRNA of ACE2 of SEQ ID NO.2 resulting in a reduction of the level of ACE2, ACE2 mRNA, ACE2 pre-mRNA or a combination thereof of 30 to 99% compared to an untreated control. The invention is further directed to a pharmaceutical composition comprising such oligonucleotide. The oligonucleotide and the pharmaceutical composition are used in a method of preventing and/or treating a viral disease.
    Type: Application
    Filed: December 31, 2021
    Publication date: February 29, 2024
    Inventors: Frank JASCHINSKI, Anne SADEWASSER, Sven MICHEL, Marta Lucia DE LOS REYES, Richard KLAR, Nan ZHANG, Claus BACHERT, Weiping WEN
  • Patent number: 9089494
    Abstract: The invention described herein includes a chemical system consisting essentially of octyl methoxycinnamate, oxybenzone, Ethylhexyl Salicylate, and Avobenzone and optionally, water. The chemical system imparts resistance to ultraviolet energy when added to cosmetic formulations, chemical formulations, and medicinal formulations.
    Type: Grant
    Filed: September 14, 2004
    Date of Patent: July 28, 2015
    Assignee: Coty S.A.
    Inventors: Rene Thomas Rivero, Frank A. Lucia, III, Vinod Topiwala
  • Publication number: 20060128579
    Abstract: The invention described herein includes a formulation comprising: a lower than expected use level of structurant/surfactant blend and an emulsion comprising a homogenized mixture of wax and alcohol components, at least one of which is a surfactant, wherein the formulation comprises a stable lamellar or spherulite phase.
    Type: Application
    Filed: July 7, 2005
    Publication date: June 15, 2006
    Inventors: Michael Knopf, Michele Polk, Frank Lucia, William Wohland, Ralph Macchio
  • Publication number: 20060057080
    Abstract: The invention described herein includes a chemical system consisting essentially of octyl methoxycinnamate, oxybenzone, Ethylhexyl Salicylate, and Avobenzone and optionally, water. The chemical system imparts resistance to ultraviolet energy when added to cosmetic formulations, chemical formulations, and medicinal formulations.
    Type: Application
    Filed: September 14, 2004
    Publication date: March 16, 2006
    Inventors: Rene Rivero, Frank Lucia, Vinod Topiwala
  • Publication number: 20060008434
    Abstract: Embodiments of the invention described herein include a formulation comprising: a deodorant, a structurant and an emulsion comprising a homogenized mixture of wax and alcohol components, at least one of which is a surfactant, wherein the formulation comprises a stable lamellar or spherulite phase.
    Type: Application
    Filed: April 8, 2005
    Publication date: January 12, 2006
    Inventors: Michael Knopf, Michele Polk, Frank Lucia, William Wohland, Ralph Macchio
  • Publication number: 20050265936
    Abstract: The invention described herein includes a sunscreen formulation comprising: a sunscreen, a structurant and an emulsion comprising a homogenized mixture of wax and alcohol components, at least one of which is a surfactant, wherein the formulation comprises a stable lamellar or spherulite phase.
    Type: Application
    Filed: April 8, 2005
    Publication date: December 1, 2005
    Inventors: Michael Knopf, Michele Polk, Frank Lucia, William Wohland, Ralph Macchio
  • Publication number: 20050025731
    Abstract: The invention described herein includes a formulation comprising: a structurant and an emulsion comprising a homogenized mixture of wax and alcohol components, at least one of which is a surfactant, wherein the formulation comprises a stable lamellar or spherulite phase.
    Type: Application
    Filed: June 15, 2004
    Publication date: February 3, 2005
    Inventors: Michael Knopf, Michele Polk, Frank Lucia, William Wohland, Ralph Macchio, Paul Seplowitz